mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.006 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.007 |
mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.01 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.01 |
mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
simvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.01 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |